Bluefin Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bluefin Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-45,475	Closed	-$1.87M	–	529
2018 Q4	$1.87M	Buy	+45,475	New	+$1.7M	0.19%	74

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bluefin Capital Management's GBT Position: Q1 2019 in Review

Bluefin Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2019, closing a stake of 45,475 shares — an estimated $1.87M sold.

Bluefin Capital Management first reported a position in GBT in Q4 2018 and held it in 1 quarter. The position peaked at $1.87M in Q4 2018. 201 funds tracked by Wall St. Rank hold GBT as of Q1 2019.

Bluefin Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Bluefin Capital Management sold 45,475 Global Blood Therapeutics, Inc. shares in Q1 2019, an estimated $1.87M.
Bluefin Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 1 quarter.
Bluefin Capital Management's Global Blood Therapeutics, Inc. position peaked at $1.87M in Q4 2018.
201 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2019.

Based on Bluefin Capital Management's 13F filing for Q1 2019, filed 16 May 2019.